Vertex Sits On $1.4bn Cash, Seeks External Innovation Away From CF

 
• By Lucie Ellis-Taitt
  
Dollar sign
Vertex has the cash to pursue new opportunies outside of cystic fibrosis • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business